Zantac Lawsuit: What Florida Residents Need to Know in 2026
For decades, millions of Americans reached for Zantac (ranitidine) to relieve heartburn and acid reflux, unaware that the medication could break down into N-nitroso dimethylamine (NDMA), a chemical the FDA classifies as a probable human carcinogen. After independent laboratory testing revealed dangerously high NDMA levels in ranitidine, the FDA requested a full market withdrawal of all Zantac products in April 2020. Since then, thousands of former users who went on to develop bladder, stomach, oesophageal, or liver cancer have filed lawsuits against manufacturers including GlaxoSmithKline, Sanofi, Pfizer, and Boehringer Ingelheim. If you or a loved one took Zantac or a generic ranitidine product regularly and later received a cancer diagnosis, the Zantac lawsuit lawyers at People for Law can review your medical history, help you collect supporting documentation, and help you understand whether you may be entitled to compensation. How Ranitidine Breaks Down into a Cancer-Causing C...